Medical Condition News

RSS

ISTA Pharmaceuticals initiates REMURA Phase 3 clinical program for dry eye disease

ISTA Pharmaceuticals, Inc., today announced that it has initiated a Phase 3 clinical program of ISTA's proprietary formulation of REMURA (bromfenac ophthalmic solution for dry eye) for alleviating the signs and symptoms of dry eye disease. The Phase 3 efficacy studies are being conducted under a Special Protocol Assessment (SPA) agreed upon with the U.S. Food and Drug Administration (FDA).

16 Sep 2010

CDPAC to work with health ministers on concrete actions to address childhood obesity

The Chronic Disease Prevention Alliance of Canada (CDPAC), a coalition comprised of ten national organizations committed to integrated action for chronic disease prevention in Canada, commends the federal, provincial and territorial ministers of health for their commitment to address the issue of childhood obesity at their meeting in St. John's Newfoundland yesterday.

16 Sep 2010

HFSA to discuss 'Designing the Medical Home for Heart Failure Patients' at Scientific Meeting

The 14th Annual Scientific Meeting of the Heart Failure Society of America (HFSA) will feature a discussion titled "Designing the Medical Home for Heart Failure Patients." Contributors Dr. Mary Norine Walsh and Dr. Larry A. Allen will describe treatment and care strategies in the medical home model and how they impact both patients and caregivers.

16 Sep 2010

Alzheimer Society, Coffee Break commits to support Canadians living with Alzheimer's disease

Today, hundreds of people across the nation have made the commitment to make their "coffee count" and are drinking a cup of coffee to raise funds in support of Canadians living with Alzheimer's disease or a related dementia. This marks 15 years' of successful grassroots fundraising by the Alzheimer Society, raising over $12 million in support of essential programs and services for people with dementia, their families and caregivers.

16 Sep 2010

Retina Implant AG presents clinical data of successful subretinal electronic implants

Retina Implant AG, a leading developer of subretinal implants for the visually impaired, today announced the presentation of findings obtained during their first human clinical trial in the form of two oral presentations at The Eye and the Chip 2010 Annual Meeting in Detroit, Mich.

16 Sep 2010

Intensive care diary entries can reduce PTSD rates: Study

Some intensive care patients develop post-traumatic stress syndrome (PTSD) after the trauma of a difficult hospital stay, and this is thought to be exacerbated by delusional or fragmentary memories of their time in the intensive care unit. Now researchers writing in BioMed Central's open access journal Critical Care have found that if staff and close relatives make a diary for patients, featuring information about their stay and accompanied by photographs, PTSD rates can be significantly reduced.

16 Sep 2010

BioCryst Pharmaceuticals announces BCX4208 compound results for treating gout

BioCryst Pharmaceuticals, Inc. announced positive top-line results from its randomized, double-blind, multi-center, placebo-controlled Phase 2 study designed to evaluate the urate-lowering activity and safety of several doses of BCX4208 alone and in combination with selected doses of allopurinol administered once-daily.

16 Sep 2010

Hormone Foundation produces two fact sheets to dispel myths of adrenal fatigue, Wilson's temperature syndrome

The Hormone Foundation, the public education affiliate of The Endocrine Society, has produced two new fact sheets to dispel myths about so-called "diseases" popularized through the Internet: adrenal fatigue and Wilson's temperature syndrome.

16 Sep 2010

NHLBI selects NuGEN to provide automated reagent solutions for expression profiling

NuGEN Technologies, the provider of innovative RNA and DNA amplification and sample preparation technologies for genomic analysis, today announced it has been selected by the National Heart, Lung, and Blood Institute (NHLBI) to provide automated reagent solutions for expression profiling of approximately 6,000 blood samples from the Framingham Heart Study.

16 Sep 2010

CDA initiates printed PDQ calculators to educate employees on real risks of disability

The Council for Disability Awareness (CDA) is making it easier for financial planners, benefit advisors, employers and human resource professionals to help people learn about their risks of becoming disabled by offering a new, printed version of the popular Personal Disability Quotient (PDQ) calculator.

16 Sep 2010

Endoscopic laser spine procedures replace traditional open back surgery

The Bonati Spine Institute, the leading center for the patented Bonati Spine Procedures for minimally invasive laser spine surgery, supports recent studies by highly respected organizations such as the Journal of the America Board of Family Medicine and Consumer Reports reporting an unnecessary growth in tests and treatments targeting back pain.

16 Sep 2010

Incyte Corporation publishes clinical trial data of INCB18424 drug for myelofibrosis treatment

Incyte Corporation, Results from a Phase I/II study of Incyte's janus kinase (JAK) inhibitor with the investigational name INCB18424 (also known as INCB018424 and INC424) were published today in The New England Journal of Medicine, demonstrating marked and durable clinical benefits in patients with myelofibrosis.

16 Sep 2010

Recommendations for developing novel therapies for hypertrophic cardiomyopathy

An abrupt, fatal heart attack in a young athlete on the playing field is a tragedy destined to repeat itself over and over until more is understood about hypertrophic cardiomyopathy (HCM), a genetic disorder that is the most common cause of sudden death in young people but which affects people of all ages.

16 Sep 2010

Anonymous Funding promotes drug development for Fragile X syndrome treatment

Funding from an anonymous wealthy family has been the secret to progress, at long last, in developing drugs that show promise for helping millions of people worldwide with Fragile X syndrome, the most common genetic cause of autism. That's the topic of a fascinating article in the current issue of Chemical & Engineering News (C&EN), ACS' weekly newsmagazine.

16 Sep 2010

Cinnamon found beneficial for regulating glucose, lowering blood sugar

A more significant use was recently discovered at the United States Department of Agriculture. Dr. John Andersonis found cinnamon beneficial for regulating glucose. In the body, sugars and starches are broken down into glucose, which then circulates in the blood.

16 Sep 2010

Researchers to conduct gene analysis for ankylosing spondylitis

A new study designed to test suspected links between genes and two immune disorders could open the door to better ways to diagnose and treat the conditions that affect a combined total of approximately 2.5 million people in the United States, report scientists at The University of Texas Health Science Center at Houston (UTHealth).

16 Sep 2010

Abbott issues statement in response to FDA's mixed vote for weight loss medication sibutramine

The U.S. Food and Drug Administration today held an Endocrinologic and Metabolic Drugs Advisory Committee to review the results of SCOUT and the weight loss medication sibutramine (sold as Meridia® in the United States).

16 Sep 2010

Scientists discover 13 genes linked to human body mass

Johns Hopkins scientists who specialize in unconventional hunts for genetic information outside nuclear DNA sequences have bagged a weighty quarry 13 genes linked to human body mass. The experiments screened the so called epigenome for key information that cells remember other than the DNA code itself and may have serious implications for preventing and treating obesity, the investigators say.

16 Sep 2010

Caregivers at higher risk for PTSD when cancer patients die in hospital

Cancer patients who die in the hospital or an intensive care unit have worse quality of life at the end-of-life, compared to patients who die at home with hospice services, and their caregivers are at higher risk for developing psychiatric illnesses during bereavement, according to a study by researchers at Dana-Farber Cancer Institute.

16 Sep 2010

Researchers target specific molecule in brain to prevent relapses in cocaine addicts

People who have used cocaine run a great risk of becoming addicted, even after long drug-free periods. Now researchers at Linköping University and their colleagues can point to a specific molecule in the brain as a possible target for treatment to prevent relapses.

16 Sep 2010

Medical Condition News

ISTA Pharmaceuticals initiates REMURA Phase 3 clinical program for dry eye disease

CDPAC to work with health ministers on concrete actions to address childhood obesity

HFSA to discuss 'Designing the Medical Home for Heart Failure Patients' at Scientific Meeting

Alzheimer Society, Coffee Break commits to support Canadians living with Alzheimer's disease

Retina Implant AG presents clinical data of successful subretinal electronic implants

Intensive care diary entries can reduce PTSD rates: Study

BioCryst Pharmaceuticals announces BCX4208 compound results for treating gout

Hormone Foundation produces two fact sheets to dispel myths of adrenal fatigue, Wilson's temperature syndrome

NHLBI selects NuGEN to provide automated reagent solutions for expression profiling

CDA initiates printed PDQ calculators to educate employees on real risks of disability

Endoscopic laser spine procedures replace traditional open back surgery

Incyte Corporation publishes clinical trial data of INCB18424 drug for myelofibrosis treatment

Recommendations for developing novel therapies for hypertrophic cardiomyopathy

Anonymous Funding promotes drug development for Fragile X syndrome treatment

Cinnamon found beneficial for regulating glucose, lowering blood sugar

Researchers to conduct gene analysis for ankylosing spondylitis

Abbott issues statement in response to FDA's mixed vote for weight loss medication sibutramine

Scientists discover 13 genes linked to human body mass

Caregivers at higher risk for PTSD when cancer patients die in hospital

Researchers target specific molecule in brain to prevent relapses in cocaine addicts

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News